Snakebite envenoming

@article{Gutirrez2017SnakebiteE,
  title={Snakebite envenoming},
  author={J. Guti{\'e}rrez and J. Calvete and A. Habib and R. Harrison and D. Williams and D. Warrell},
  journal={Nature Reviews Disease Primers},
  year={2017},
  volume={3}
}
Snakebite envenoming is a neglected tropical disease that kills >100,000 people and maims >400,000 people every year. Impoverished populations living in the rural tropics are particularly vulnerable; snakebite envenoming perpetuates the cycle of poverty. Snake venoms are complex mixtures of proteins that exert a wide range of toxic actions. The high variability in snake venom composition is responsible for the various clinical manifestations in envenomings, ranging from local tissue damage to… Expand

Paper Mentions

Interventional Clinical Trial
The aim of the study is to identify an 'optimal' initial dosing of the new Burma Pharmaceutical Industry (BPI) lyophilized mono-specific antivenom for patients with systemic… Expand
ConditionsDaboia Siamensis Envenoming
InterventionBiological
Interventional Clinical Trial
This is a multicenter, randomized, double-blind, placebo-controlled, phase 2 study designed to evaluate the safety, tolerability and efficacy of varespladib-methyl, concurrently with… Expand
ConditionsSnakebites
InterventionDrug
Snakebite Envenoming Diagnosis and Diagnostics
TLDR
This review aims to highlight regional differences in epidemiology and clinical snakebite management on a global scale, including an overview of the past and ongoing research efforts within snakebite diagnostics. Expand
PLOS Neglected Tropical Diseases broadens its coverage of envenomings caused by animal bites and stings
TLDR
To broaden the coverage of a variety of conditions that share the features of currently recognized neglected tropical diseases, PLOS Neglected Tropical Diseases will accept manuscripts dealing with scorpions and spiders, insects, jellyfish, and other marine creatures, in addition to snakebite envenoming. Expand
Cost of Manufacturing for Recombinant Snakebite Antivenoms
TLDR
The development of recombinant antivenoms not only holds a promise for improving therapeutic parameters, such as safety and efficacy, but could possibly also lead to a more competetive cost of manufacture of antivenom products for patients worldwide. Expand
Evolution Bites — Timeworn Inefficacious Snakebite Therapy in the Era of Recombinant Vaccines
TLDR
The influence of ecology and evolution in driving inter- and intra-specific venom variations in snakes is highlighted, and the repercussions of this molecular variation on the effectiveness of the current generation Indian antivenoms in mitigating snakebite pathologies are described. Expand
Ketamine for pain control of snake envenomation in Guinea: A case series.
TLDR
Ketamine appears to be an effective means of pain control for those suffering from painful envenomations and may provide a cheap, safe, and effective solution for Sub-saharan Africa and other resource-limited settings. Expand
Review Article: Snake Envenomation in Africa
TLDR
With the new designation of snakebite envenoming as a category A neglected tropical disease, an active WHO working group, and several independent groups focusing on a multidisciplinary approach to improve key gaps in knowledge and apply new treatment modalities, it can greatly decrease the morbidity and mortality associated with snakebite in Africa. Expand
Edema, hyperalgesia and myonecrosis induced by Brazilian bothropic venoms: Overview of the last decade.
TLDR
The edematogenic, hyperalgesic and myotoxic effects caused by Brazilian bothropic venoms are analyzed in order to contribute to the study and elucidation of the mechanisms of action of its components and enable discoveries of more effective combined therapies in the treatment of local damages resulting from envenoming. Expand
Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite
TLDR
It is demonstrated that the safe and affordable repurposed metal chelator DMPS can effectively neutralize saw-scaled viper venoms in vitro and in vivo and highlight the promise of this drug as an early, prehospital, therapeutic intervention for hemotoxic snakebite envenoming. Expand
Acute Coronary Syndrome From Green Snake Envenomation.
TLDR
The first case of unstable angina caused by Colubridae snake bite in a young man without comorbidities is reported, and the diagnosis should be considered promptly even with a nonvenomous snake bite, especially in those with typical symptoms and ECG changes. Expand
Interventions for the management of snakebite envenoming: An overview of systematic reviews
TLDR
High quality evidence from SRs is required to inform guidelines and health system decisions which can bring down the burden of snakebite, and the need to fund high-quality SRs, evidence gaps and core outcome sets which can inform guideline recommendations, funding priorities for conduct of future trials is indicated. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 165 REFERENCES
Snakebite envenoming from a global perspective: Towards an integrated approach.
TLDR
An integrated multifocal approach, currently being fostered by the Global Snake Bite Initiative of the International Society on Toxinology and by the World Health Organization, will help to alleviate the enormous burden of human suffering inflicted by snakebite envenoming. Expand
From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
TLDR
Current state of the-art in biopharmaceutical antitoxin development is presented together with an overview of available bioinformatics and structural data on snake venom toxins, which could define the basis for introducing a rational drug design approach into the field of snakebite envenoming therapy. Expand
Snake Envenoming: A Disease of Poverty
TLDR
This study unequivocally demonstrates that snake envenoming is a disease of the poor, and the negative association between snakebite deaths and government expenditure on health confirms that the burden of mortality is highest in those countries least able to deal with the considerable financial cost of snakebite. Expand
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
TLDR
Recombinant antivenom based on oligoclonal mixtures of human IgG antibodies produced by CHO cell cultivation may be the key to obtaining better snakebite envenoming therapies and may in the future be a cost-competitive alternative to existing serum-based antivenoms. Expand
The Global Snake Bite Initiative: an antidote for snake bite
TLDR
The burden of human suffering caused by snake bite remains un-recognised, invisible, and unheard by the global public health community, forgotten by development agencies and governments alike. Expand
Neurological complications of venomous snake bites: a review
TLDR
Proper management of the envenomed patient, including prompt transport to the hospital, correction of the hemostatic disorder, ventilatory support, and administration of antivenom, significantly reduces the risk of neurological complications which, in turn, reduces the mortality and improve the functional outcome of survivors. Expand
Bothrops lanceolatus Bites: Guidelines for Severity Assessment and Emergent Management
TLDR
Despite an increasing incidence of bites, no deaths have been recently attributed to B. lanceolatus in Martinique, probably due to the currently recommended strategy of early antivenom administration when required, which is effective to prevent severe thrombosis and coagulopathy. Expand
Effects of Bothrops asper Snake Venom on Lymphatic Vessels: Insights into a Hidden Aspect of Envenomation
TLDR
Observations indicate that B. asper venom affects collecting lymphatic vessels through the action of myotoxic PLA2s on the smooth muscle of these vessels, inducing cell contraction and irreversible cell damage. Expand
Epidemiological aspects of snake bites on a Liberian rubber plantation.
TLDR
During a one-year period 95 patients with a history of snake bite were admitted to the hospital of a Liberian rubber plantation, and a definite maximum of snake bites was observed during October and November which corresponds to the transition from rainy to dry season. Expand
Snake Bite in South Asia: A Review
TLDR
The deficiency of snake bite management in South Asia is multi-causal and requires joint collaborative efforts from researchers, antivenom manufacturers, policy makers, public health authorities and international funders. Expand
...
1
2
3
4
5
...